Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

HSV ICP0 recruits USP7 to modulate TLR-mediated innate response.

Daubeuf S, Singh D, Tan Y, Liu H, Federoff HJ, Bowers WJ, Tolba K.

Blood. 2009 Apr 2;113(14):3264-75. doi: 10.1182/blood-2008-07-168203. Epub 2008 Oct 24.

2.

Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-kappaB signaling.

van Lint AL, Murawski MR, Goodbody RE, Severa M, Fitzgerald KA, Finberg RW, Knipe DM, Kurt-Jones EA.

J Virol. 2010 Oct;84(20):10802-11. doi: 10.1128/JVI.00063-10. Epub 2010 Aug 4.

3.

Identification of a novel higher molecular weight isoform of USP7/HAUSP that interacts with the Herpes simplex virus type-1 immediate early protein ICP0.

Antrobus R, Boutell C.

Virus Res. 2008 Oct;137(1):64-71. doi: 10.1016/j.virusres.2008.05.017. Epub 2008 Jul 17.

PMID:
18590780
4.
5.

Structural Characterization of Interaction between Human Ubiquitin-specific Protease 7 and Immediate-Early Protein ICP0 of Herpes Simplex Virus-1.

Pozhidaeva AK, Mohni KN, Dhe-Paganon S, Arrowsmith CH, Weller SK, Korzhnev DM, Bezsonova I.

J Biol Chem. 2015 Sep 18;290(38):22907-18. doi: 10.1074/jbc.M115.664805. Epub 2015 Jul 29.

7.

Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.

Conn KL, Wasson P, McFarlane S, Tong L, Brown JR, Grant KG, Domingues P, Boutell C.

J Virol. 2016 Apr 14;90(9):4807-26. doi: 10.1128/JVI.03055-15. Print 2016 May.

9.

A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7.

Canning M, Boutell C, Parkinson J, Everett RD.

J Biol Chem. 2004 Sep 10;279(37):38160-8. Epub 2004 Jul 6.

11.

Herpes virus proteins ICP0 and BICP0 can activate NF-kappaB by catalyzing IkappaBalpha ubiquitination.

Diao L, Zhang B, Fan J, Gao X, Sun S, Yang K, Xin D, Jin N, Geng Y, Wang C.

Cell Signal. 2005 Feb;17(2):217-29.

PMID:
15494213
12.

Crystal Structure of USP7 Ubiquitin-like Domains with an ICP0 Peptide Reveals a Novel Mechanism Used by Viral and Cellular Proteins to Target USP7.

Pfoh R, Lacdao IK, Georges AA, Capar A, Zheng H, Frappier L, Saridakis V.

PLoS Pathog. 2015 Jun 5;11(6):e1004950. doi: 10.1371/journal.ppat.1004950. eCollection 2015 Jun.

13.

ICP0 dismantles microtubule networks in herpes simplex virus-infected cells.

Liu M, Schmidt EE, Halford WP.

PLoS One. 2010 Jun 8;5(6):e10975. doi: 10.1371/journal.pone.0010975.

14.

TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA.

Konno H, Yamamoto T, Yamazaki K, Gohda J, Akiyama T, Semba K, Goto H, Kato A, Yujiri T, Imai T, Kawaguchi Y, Su B, Takeuchi O, Akira S, Tsunetsugu-Yokota Y, Inoue J.

PLoS One. 2009 May 25;4(5):e5674. doi: 10.1371/journal.pone.0005674.

15.

Ubiquitin-specific protease 4 mitigates Toll-like/interleukin-1 receptor signaling and regulates innate immune activation.

Zhou F, Zhang X, van Dam H, Ten Dijke P, Huang H, Zhang L.

J Biol Chem. 2012 Mar 30;287(14):11002-10. doi: 10.1074/jbc.M111.328187. Epub 2012 Jan 19.

16.
17.

The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0.

Lilley CE, Chaurushiya MS, Boutell C, Everett RD, Weitzman MD.

PLoS Pathog. 2011 Jun;7(6):e1002084. doi: 10.1371/journal.ppat.1002084. Epub 2011 Jun 16.

18.

Herpes simplex virus disrupts NF-kappaB regulation by blocking its recruitment on the IkappaBalpha promoter and directing the factor on viral genes.

Amici C, Rossi A, Costanzo A, Ciafrè S, Marinari B, Balsamo M, Levrero M, Santoro MG.

J Biol Chem. 2006 Mar 17;281(11):7110-7. Epub 2006 Jan 3.

20.

Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.

Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, Cody MJ, Michalek SM, Rice NR, Vogel SN.

J Immunol. 2003 Jan 1;170(1):508-19.

Items per page

Supplemental Content

Write to the Help Desk